SCHEMBL5048013

SCHEMBL5048013

Cn1ncc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 2/20 0.43
NOTUM Q6P988 2/20 0.41
METAP2 P50579 1/20 0.41
TP53 P04637 3/20 0.41
USP2 O75604 1/20 0.41
MAPK1 P28482 1/20 0.41
NPC1 O15118 6/20 0.40
RAB9A P51151 6/20 0.40
MAPT P10636 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
KCNH2 Q12809 2/20 0.39
GRIN2B Q13224 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM3 P20309 1/20 0.39
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23328880 0.81 AOC3 (0.42) AOC3NOTUMTP53USP2NPC1
SCHEMBL21412297 0.80 AOC3 (0.47) AOC3TP53USP2NPC1RAB9A
SCHEMBL5047902 0.80 AOC3 (0.47) AOC3NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL5053616 0.80 AOC3 (0.47) AOC3METAP2TP53MAPK1NPC1
SCHEMBL11730368 0.80 KEAP1 (0.55) AOC3METAP2TP53NPC1RAB9A
Ammonia Solution, Strong SCHEMBL28862485 0.80 AOC3 (0.43) AOC3NOTUMMETAP2TP53NPC1
SCHEMBL5049537 0.79 AHR (0.45) AOC3NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL5049416 0.77 CHRM2 (0.43) NOTUMMETAP2MAPK1NPC1RAB9A
SCHEMBL5047974 0.77 AOC3 (0.51) AOC3MAPK1NPC1RAB9AMAPT
SCHEMBL22918654 0.76 AOC3 (0.50) AOC3CHRM2CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP claimed
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP disclosed